# Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)

> **NCT05193591** · — · RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 30 (estimated)

## Conditions studied

- Lupus Erythematosus, Systemic

## Interventions

- **OTHER:** Autoantibodies evaluation in lupus

## Key facts

- **NCT ID:** NCT05193591
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-11
- **Primary completion:** 2025-09-10
- **Final completion:** 2025-09-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193591, "Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05193591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*